SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aetna Inc. (AET) trades at a trailing P/E of 11.6. Trailing earnings yield is 8.61%. PEG 0.27 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (11.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.27); earnings yield beats bond yields (8.61%).
- PEG Ratio 0.27 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.61% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AET
Valuation Multiples
P/E (TTM)11.6
Forward P/EN/A
PEG Ratio0.27
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.57
EV/EBITDA0.0
Per Share Data
EPS (TTM)$9.16
Book Value / Share$0.00
Revenue / Share$185.24
FCF / Share$0.00
Yields & Fair Value
Earnings Yield8.61%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2008 |
$3.00 |
$30.95B |
$1.38B |
4.5% |
| 2009 |
$2.96 |
$34.76B |
$1.28B |
3.7% |
| 2010 |
$4.18 |
$34.25B |
$1.77B |
5.2% |
| 2011 |
$5.22 |
$33.78B |
$1.99B |
5.9% |
| 2012 |
$4.81 |
$36.6B |
$1.66B |
4.5% |
| 2013 |
$5.33 |
$47.29B |
$1.91B |
4% |
| 2014 |
$5.68 |
$58B |
$2.04B |
3.5% |
| 2015 |
$6.78 |
$60.34B |
$2.39B |
4% |
| 2016 |
$6.41 |
$63.16B |
$2.27B |
3.6% |
| 2017 |
$9.16 |
$60.54B |
$1.9B |
3.1% |
